My only post on the subject:

PTSC pps is where it is IMO since PTSC does not have a 'product' other than the patent. Although there have been rumors that a M+A is in the works, at this point, nothing has been finailized. Once PTSC is able to show consistent and forecastable earnings, the pps will reflect such. Granted, it's possible that licensing efforts alone can increase the pps, especially when it's considered that with enough licenses, PTSC will have more cash per share than its current pps.

EDIG, on the other hand, has a product that is currently producing ongoing revenues, in addition to the patents which we all feel will be validated by the Court. When EDIG shows true growth with the product, and results of the monetization of its patents, EDIG will likely have the better chance to show a more significant gain overall than PTSC.... assuming that PTSC does not make any announcements on the M+A front in the meantime.